Clinical Trial Results:
A randomised, double-blind, 8 treatments, 4 periods, incomplete crossover
study to determine the optimal free dose combination of
BI 1744 CL and tiotropium bromide (both delivered by the Respimat®
Inhaler) after 4 weeks once daily treatment in patients with COPD
Summary
|
|
EudraCT number |
2009-014880-38 |
Trial protocol |
NL DE SE |
Global completion date |
03 Feb 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
10 Mar 2016
|
First version publication date |
10 Mar 2016
|
Other versions |
|
Summary report(s) |
Trial Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.